Neuropharmacology of Fisetin as a Senotherapeutic Agent: Investigating Its Role in Neurodegeneration and Brain Aging

Fisetin in Neurodegeneration and Aging

Authors

  • Sidra Javaid Department of Internal Medicine, Services Hospital Lahore, Lahore, Pakistan
  • Abeer Memon Department of Medicine, Liaquat University of Medical and Health Sciences, Jamshoro, Pakistan
  • Binish Anwar Department of Pharmacology, Shalamar Medical and Dental College, Lahore, Pakistan
  • Zarafshan Bader Department of Pharmacology, Foundation University, Islamabad, Pakistan
  • Ayesha Aftab Department of Pharmacology, Al Nafees Medical College and Hospital, Islamabad, Pakistan
  • Fouzia Perveen Department of Pharmacology, Sharif Medical and Dental College, Lahore, Pakistan
  • Ehsan Ul Haq Institute of Allied Health Sciences, University of Health Sciences, Lahore, Pakistan

DOI:

https://doi.org/10.54393/pjhs.v5i11.2399

Keywords:

Fisetin, Neuroprotection, Neurodegeneration, Brain Aging, Cellular Senescence

Abstract

Fisetin, a flavonoid in various fruits and vegetables, has emerged as a promising chemotherapeutic agent with potential neuroprotective effects, particularly in neurodegeneration and brain aging. Objective: To explore the role of fisetin in mitigating age-related neuronal damage by targeting oxidative stress, inflammation, and cellular senescence, common contributors to neurodegenerative diseases such as Alzheimer's and Parkinson's. Methods: Following PRISMA guidelines, relevant studies were sourced from ScienceDirect, Google Scholar, and PubMed, spanning publications between April 2014 and August 2024. One website was also used to retrieve studies, i.e., Frontiers. Fisetin's mechanism of action includes modulating key pathways, such as the inhibition of inflammatory markers, reduction of Reactive Oxygen Species (ROS), and protection against neuronal apoptosis. Results: Studies conducted on various animal models and human-derived neurodegenerative cell lines reveal its potential to improve cognitive function and reduce the progression of age-related brain disorders. Conclusions: Fisetin's ability to selectively target senescent cells, reduce neuroinflammation, and enhance synaptic function positions it as a potential therapeutic for brain aging. Future research focusing on clinical trials and dosing optimization was crucial to establishing fisetin as a viable treatment for neurodegenerative conditions and cognitive decline associated with aging.

References

Huang Y, Li Y, Pan H, Han L. Global, regional, and national burden of neurological disorders in 204 countries and territories worldwide. Journal of Global Health. 2023 Nov; 13: 04160. doi: 10.7189/jogh.13.04160.

Singh G, Sharma M, Kumar GA, Rao NG, Prasad K, Mathur P et al. The burden of neurological disorders across the states of India: the Global Burden of Disease Study 1990-2019. The Lancet Global Health. 2021 Aug; 9(8): e1129-44. doi: 10.1016/S2214-109X(21)00164-9.

Skariah G and Todd PK. Translational control in aging and neurodegeneration. Wiley Interdisciplinary Reviews: RNA. 2021 Jul; 12(4): e1628. doi: 10.1002/wrna.1628.

Dewanjee S, Chakraborty P, Bhattacharya H, Chacko L, Singh B, Chaudhary A et al. Altered glucose metabolism in Alzheimer's disease: role of mitochondrial dysfunction and oxidative stress. Free Radical Biology and Medicine. 2022 Nov; 193: 134-57. doi: 10.1016/j.freeradbiomed.2022.09.032.

Lemoine M. The evolution of the hallmarks of aging. Frontiers in Genetics. 2021 Aug; 12: 693071. doi: 10.3389/fgene.2021.693071.

Hou Y, Dan X, Babbar M, Wei Y, Hasselbalch SG, Croteau DL et al. Aging as a risk factor for neurodegenerative disease. Nature Reviews Neurology. 2019 Oct; 15(10): 565-81. doi: 10.1038/s41582-019-0244-7.

Ladiges WL, Tchkonia T, Kirkland JL, Robbins PD, Niedernhofer LJ. Fisetin is a senotherapeutic that extends health and lifespan. 2018 Oct: 36: 18-28. doi: 10.1016/j.ebiom.2018.09.015.

Hassan SS, Samanta S, Dash R, Karpiński TM, Habibi E, Sadiq A et al. The neuroprotective effects of fisetin, a natural flavonoid in neurodegenerative diseases: Focus on the role of oxidative stress. Frontiers in Pharmacology. 2022 Oct; 13: 1015835. doi: 10.3389/fphar.2022.1015835.

Farihi A, Bouhrim M, Chigr F, Elbouzidi A, Bencheikh N, Zrouri H et al. Exploring Medicinal Herbs' Therapeutic Potential and Molecular Docking Analysis for Compounds as Potential Inhibitors of Human Acetylcholinesterase in Alzheimer's Disease Treatment. Medicina. 2023 Oct; 59(10): 1812. doi: 10.3390/medicina59101812.

Takaya K, Asou T, Kishi K. Fisetin, a potential skin rejuvenation drug that eliminates senescent cells in the dermis. Biogerontology. 2024 Feb; 25(1): 161-75. doi: 10.1007/s10522-023-10064-9.

Park S, Kim BK, Park SK. Effects of fisetin, a plant-derived flavonoid, on response to oxidative stress, aging, and age-related diseases in Caenorhabditis elegans. Pharmaceuticals. 2022 Dec; 15(12): 1528. doi: 10.3390/ph15121528.

Si W, Zhang Y, Li X, Du Y, Xu Q. Understanding the functional activity of polyphenols using omics-based approaches. Nutrients. 2021 Nov; 13(11): 3953. doi: 10.3390/nu13113953.

N Syed D, M Adhami V, Imran Khan M, Mukhtar H. Inhibition of Akt/mTOR signaling by the dietary flavonoid fisetin. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents). 2013 Sep; 13(7): 995-1001. doi: 10.2174/18715206113139990129.

Shafique A, Akram S, Mushtaq M. Fisetin: a senolytic drug. InA Centum of Valuable Plant Bioactives 2021 Jan 1 (pp. 379-401). Academic Press. doi: 10.1016/B978-0-12-822923-1.00002-9.

Zhong R, Miao L, Zhang H, Tan L, Zhao Y, Tu Y et al. Anti-inflammatory activity of flavonols via inhibiting MAPK and NF-κB signaling pathways in RAW264. 7 macrophages. Current Research in Food Science. 2022 Jan; 5: 1176-84. doi: 10.1016/j.crfs.2022.07.007.

Lee E, Carreras-Gallo N, Lopez L, Turner L, Lin A, Mendez TL et al. Exploring the effects of Dasatinib, Quercetin, and Fisetin on DNA methylation clocks: a longitudinal study on senolytic interventions. Aging (Albany NY). 2024 Feb; 16(4): 3088. doi: 10.18632/aging.205581.

Maher P. Modulation of the neuroprotective and anti-inflammatory activities of the flavonol fisetin by the transition metals iron and copper. Antioxidants. 2020 Nov; 9(11): 1113. doi: 10.3390/antiox9111113.

Wang Y, Wu X, Ren W, Liu Y, Dai X, Wang S et al. Protective effects of fisetin in an Aβ1-42-induced rat model of Alzheimer's disease. Folia Neuropathologica. 2023 Jan; 61(2): 196-208. doi: 10.5114/fn.2023.126893.

Zhang S, Xue R, Geng Y, Wang H, Li W. Fisetin prevents HT22 cells from high glucose-induced neurotoxicity via PI3K/Akt/CREB signaling pathway. Frontiers in Neuroscience. 2020 Mar; 14: 241. doi: 10.3389/fnins.2020.00241.

Chen TJ, Feng Y, Liu T, Wu TT, Chen YJ, Li X et al. Fisetin regulates gut microbiota and exerts neuroprotective effect on mouse model of Parkinson's disease. Frontiers in Neuroscience. 2020 Dec; 14: 549037. doi: 10.3389/fnins.2020.549037.

Ahmad S, Khan A, Ali W, Jo MH, Park J, Ikram M et al. Fisetin rescues the mice brains against D-galactose-induced oxidative stress, neuroinflammation and memory impairment. Frontiers in Pharmacology. 2021 Feb; 12: 612078. doi: 10.3389/fphar.2021.612078.

Li X, He Z, Wang C, Liu Y, Shan Z, Zhang L et al. Effect of herbal medicinal compounds on Alzheimer's disease pathology in APP/PS1 transgenic mouse model. Natural Product Communications. 2020 Aug; 15(8): 1934578X20948986. doi: 10.1177/1934578X20948986.

Ay M. Evaluation of fisetin as a potential inducer of mitochondrial biogenesis in SH-SY5Y neuronal cells. Iranian Journal of Basic Medical Sciences. 2023; 26(11): 1320. doi: 10.22038/IJBMS.2023.72272.15714.

Rosado-Ramos R, Godinho-Pereira J, Marques D, Figueira I, Fleming Outeiro T, Menezes R et al. Small molecule fisetin modulates alpha-synuclein aggregation. Molecules. 2021 Jun; 26(11): 3353. doi: 10.3390/molecules26113353.

Elsallabi O, Patruno A, Pesce M, Cataldi A, Carradori S, Gallorini M. Fisetin as a senotherapeutic agent: biopharmaceutical properties and crosstalk between cell senescence and neuroprotection. Molecules. 2022 Jan; 27(3): 738. doi: 10.3390/molecules27030738.

Renault-Mahieux M, Vieillard V, Seguin J, Espeau P, Le DT, Lai-Kuen R et al. Co-encapsulation of fisetin and cisplatin into liposomes for glioma therapy: from formulation to cell evaluation. Pharmaceutics. 2021 Jun; 13(7): 970. doi: 10.3390/pharmaceutics13070970.

Mbara KC, Devnarain N, Owira PM. Potential role of polyphenolic flavonoids as senotherapeutic agents in degenerative diseases and geroprotection. Pharmaceutical Medicine. 2022 Dec; 36(6): 331-52. doi: 10.1007/s40290-022-00444-w.

Akpa AR, Ayo JO, Mika'il HG, Zakari FO. Protective effect of fisetin against subchronic chlorpyrifos-induced toxicity on oxidative stress biomarkers and neurobehavioral parameters in adult male albino mice. Toxicological Research. 2021 Apr; 37: 163-71. doi: 10.1007/s43188-020-00049-y.

Xiao S, Lu Y, Wu Q, Yang J, Chen J, Zhong S et al. Fisetin inhibits tau aggregation by interacting with the protein and preventing the formation of β-strands. International Journal of Biological Macromolecules. 2021 May; 178:381-93. doi: 10.1016/j.ijbiomac.2021.02.210.

Yang W, Tian ZK, Yang HX, Feng ZJ, Sun JM, Jiang H et al. Fisetin improves lead-induced neuroinflammation, apoptosis and synaptic dysfunction in mice associated with the AMPK/SIRT1 and autophagy pathway. Food and Chemical Toxicology. 2019 Dec; 134: 110824. doi: 10.1016/j.fct.2019.110824.

Martel J, Ojcius DM, Wu CY, Peng HH, Voisin L, Perfettini JL et al. Emerging use of senolytics and senomorphics against aging and chronic diseases. Medicinal Research Reviews. 2020 Nov; 40(6): 2114-31. doi: 10.1002/med.21702.

Azam S, Haque ME, Balakrishnan R, Kim IS, Choi DK. The aging brain: molecular and cellular basis of neurodegeneration. Frontiers in Cell and Developmental Biology. 2021 Aug; 9: 683459. doi: 10.3389/fcell.2021.683459.

Feigin VL, Vos T, Nichols E, Owolabi MO, Carroll WM, Dichgans M et al. The global burden of neurological disorders: translating evidence into policy. The Lancet Neurology. 2020 Mar; 19(3): 255-65. doi: 10.1016/S1474-4422(19)30411-9.

Wyles SP, Tchkonia T, Kirkland JL. Targeting cellular senescence for age-related diseases: path to clinical translation. Plastic and Reconstructive Surgery. 2022 Oct; 150: 20S-6S. doi: 10.1097/PRS.0000000000009669.

Rauf A, Abu-Izneid T, Imran M, Hemeg HA, Bashir K, Aljohani AS et al. Therapeutic potential and molecular mechanisms of the multitargeted flavonoid fisetin. Current Topics in Medicinal Chemistry. 2023 Aug; 23(21): 2075-96. doi: 10.2174/1568026623666230710162217.

Jazvinšćak Jembrek M, Oršolić N, Mandić L, Sadžak A, Šegota S. Anti-oxidative, anti-inflammatory and anti-apoptotic effects of flavonols: targeting Nrf2, NF-κB and p53 pathways in neurodegeneration. Antioxidants. 2021 Oct; 10(10): 1628. doi: 10.3390/antiox10101628.

Ravula AR, Teegala SB, Kalakotla S, Pasangulapati JP, Perumal V, Boyina HK. Fisetin, potential flavonoid with multifarious targets for treating neurological disorders: An updated review. European Journal of Pharmacology. 2021 Nov; 910: 174492. doi: 10.1016/j.ejphar.2021.174492.

Carreras-Gallo N, Dargham R, Thorpe S, Warren S, Mendez TL, Smith R et al. The Impact of a Natural Ingredients based Intervention Targeting the Nine Hallmarks of Aging on DNA methylation. bioRxiv. 2024 Sep: 2024-09. doi: 10.1101/2024.09.02.610828.

ul Islam B, Suhail M, Khan MS, Ahmad A, Zughaibi TA, Husain FM et al. Flavonoids and PI3K/Akt/mTOR signaling cascade: a potential crosstalk in anticancer treatment. Current Medicinal Chemistry. 2021 Dec; 28(39): 8083-97. doi: 10.2174/0929867328666210804091548.

Chen J, Ma D, He L, Yang D. Senolystics from natural products for extending health and lifespan. Traditional Medicine Research. 2024; 9: 67. doi: 10.53388/TMR20240423001.

Antika LD and Dewi RM. Pharmacological aspects of fisetin. Asian Pacific Journal of Tropical Biomedicine. 2021 Jan; 11(1): 1-9. doi: 10.4103/2221-1691.300726.

Sundarraj K, Raghunath A, Panneerselvam L, Perumal E. Fisetin inhibits autophagy in HepG2 cells via PI3K/Akt/mTOR and AMPK pathway. Nutrition and Cancer. 2021 Dec; 73(11-12): 2502-14. doi: 10.1080/01635581.2020.1836241.

Tang X, Deng P, Jiang Y, Zhang L, He Y, Yang H. An Overview of Recent Advances in the Neuroprotective Potentials of Fisetin against Diverse Insults in Neurological Diseases and the Underlying Signaling Pathways. Biomedicines. 2023 Oct; 11(11): 2878. doi: 10.3390/biomedicines11112878.

Currais A, Prior M, Dargusch R, Armando A, Ehren J, Schubert D et al. Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in A lzheimer's disease transgenic mice. Aging cell. 2014 Apr; 13(2): 379-90. doi: 10.1111/acel.12185.

Ahmad A, Ali T, Rehman SU, Kim MO. Phytomedicine-based potent antioxidant, fisetin protects CNS-insult LPS-induced oxidative stress-mediated neurodegeneration and memory impairment. Journal of Clinical Medicine. 2019 Jun; 8(6): 850. doi: 10.3390/jcm8060850.

Nabizadeh F. Neuroprotective role of Fisetin in Alzheimer's disease: An overview of potential mechanism and clinical findings. Neurology Letters. 2024 Jun; 3: 14-25. doi: 10.61186/nl.3.2.14.

Bjørklund G, Oliinyk P, Khavrona O, Lozynska I, Lysiuk R, Darmohray R et al. The Effects of Fisetin and Curcumin on Oxidative Damage Caused by Transition Metals in Neurodegenerative Diseases. Molecular Neurobiology. 2024 Jul: 1-22. doi: 10.1007/s12035-024-04321-2.

Ren Q, Jiang J, Huang P, Liang X, He C, Zhou Z et al. Novel Supramolecular Nanoparticles Modified with Phosphatidylcholine Improve the Bioavailability of Fisetin and Alleviate Alcoholism through Antioxidant and Antiinflammatory Effects. ACS Applied Nano Materials. 2024 Sep; 7(18): 22313-28. doi: 10.1021/acsanm.4c04843.

Khayatan D, Razavi SM, Arab ZN, Khanahmadi M, Samanian A, Momtaz S et al. Protective Effects of Plant-Derived Compounds Against Traumatic Brain Injury. Molecular Neurobiology. 2024 Mar: 1-9. doi: 10.1007/s12035-024-04030-w.

Downloads

Published

2024-11-30
CITATION
DOI: 10.54393/pjhs.v5i11.2399
Published: 2024-11-30

How to Cite

Javaid, S., Memon, A., Anwar, B., Bader, Z., Aftab, A., Perveen, F., & Haq, E. U. (2024). Neuropharmacology of Fisetin as a Senotherapeutic Agent: Investigating Its Role in Neurodegeneration and Brain Aging: Fisetin in Neurodegeneration and Aging. Pakistan Journal of Health Sciences, 5(11). https://doi.org/10.54393/pjhs.v5i11.2399

Issue

Section

Systematic Review

Plaudit